Literature DB >> 8215015

Insulin-like growth factors.

D LeRoith1, C T Roberts.   

Abstract

The purpose of this review has been to emphasize, in general terms, the major aspects of the structure, expression, and regulation of the IGF-I and IGF-II genes. The complex organization of these genes provides ample opportunities for control of gene expression at multiple levels. It is important to realize that regulation at one level can influence regulation at a different level. While such regulatory interactions are characteristic of both the IGF-I and IGF-II genes, they are particularly evident in the case of IGF-I gene expression. For example, the choice of transcription start site influences the length and the sequence of the 5'-UTR, which can influence mRNA translatability and prepeptide sequence, which may influence the amounts of protein produced and, potentially, the intracellular processing and secretion of the final gene product, the mature hormone. Another example is provided by the alternative splicing of E-peptide-encoding exons, which determines the primary structure of the prohormone, which could influence its processing, stability, or function. Thus, this complex gene organization may reflect the need to carefully control, through a multilevel process, the synthesis, processing, and secretion of these important regulatory peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215015     DOI: 10.1111/j.1749-6632.1993.tb26200.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

2.  Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression.

Authors:  K Savitsky; M Platzer; T Uziel; S Gilad; A Sartiel; A Rosenthal; O Elroy-Stein; Y Shiloh; G Rotman
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

Review 3.  Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Authors:  Mónica Enguita-Germán; Puri Fortes
Journal:  World J Hepatol       Date:  2014-10-27

4.  IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.

Authors:  Yan Zhou; Cheng Zeng; Xin Li; Pei-Li Wu; Ling Yin; Xiao-Lan Yu; Ying-Fang Zhou; Qing Xue
Journal:  J Mol Med (Berl)       Date:  2016-02-22       Impact factor: 4.599

5.  Gene expression profile in prion protein-deficient fibroblasts in culture.

Authors:  J Satoh; Y Kuroda; S Katamine
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Association of insulin-like growth factor-1 with thyroid nodules.

Authors:  Ying-Jian Liu; Wei Qiang; Xing-Jun Liu; Li Xu; Hui Guo; Li-Ping Wu; Bingyin Shi
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

Review 7.  Brain repair and neuroprotection by serum insulin-like growth factor I.

Authors:  Eva Carro; Jose Luis Trejo; Angel Núñez; Ignacio Torres-Aleman
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 8.  Biological effects of growth hormone on carbohydrate and lipid metabolism.

Authors:  Archana Vijayakumar; Ruslan Novosyadlyy; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Growth Horm IGF Res       Date:  2009-10-01       Impact factor: 2.372

9.  Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I.

Authors:  Murat Digicaylioglu; Gwenn Garden; Sonia Timberlake; Lauren Fletcher; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 10.  Animal models of colitis-associated carcinogenesis.

Authors:  Manasa Kanneganti; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  J Biomed Biotechnol       Date:  2011-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.